ArticleWorld journal of gastrointestinal surgery2024

FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma.

Xian-Ze Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.